Early supplementation of Saccharomyces cerevisiae boulardii CNCM I-1079 in newborn dairy calves increases IgA production in the intestine at 1 week of age

被引:35
|
作者
Villot, C. [1 ,2 ]
Chen, Y. [1 ,3 ]
Pedgerachny, K. [1 ]
Chaucheyras-Durand, F. [2 ]
Chevaux, E. [2 ]
Skidmore, A. [4 ]
Guan, L. L. [1 ]
Steele, M. A. [1 ,5 ]
机构
[1] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada
[2] Lallemand SAS, F-31702 Blagnac, France
[3] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB T1J 4B1, Canada
[4] Lallemand Specialties Inc, Milwaukee, WI 53218 USA
[5] Univ Guelph, Dept Anim Biosci, Guelph, ON N1G 2W1, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
supplementation; immunoglobulin; yeast; immunity; SECRETORY ANTIBODIES; IMMUNE-SYSTEM; SERUM; COLOSTRUM; IMMUNOGLOBULINS; ESTABLISHMENT; PROBIOTICS; TRANSPORT; COMPONENT; BACTERIA;
D O I
10.3168/jds.2020-18274
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
The early development of immunity and microbiota in the gut of newborn calves can have life-long consequences. Gut microbiota and the intestinal barrier interplay after birth, establishing a homeostatic state whereby mucosal cells cohabit with microorganisms to develop a healthy gut. We hypothesized that postnatal codevelopment of gut immunity and microbiota could be influenced by early-life supplementation with live yeast. Starting from birth, calves either received a daily supplementation of Saccharomyces cerevisiae boulardii CNCM I-1079 (SCB, 10 x 10(9) cfu/d, n = 10) in the morning meal for 7 d or no supplementation (n = 10). Each animal received 2 adequate colostrum replacer meals at 2 and 12 h of life (expected total IgG fed = 300 g) before being fed milk replacer twice a day. Passive transfer of immunity (total protein, IgG, and IgA) through colostrum was evaluated and endogenous production of IgA was investigated by measuring IgA-producing plasma cells, IgA relative gene expression (PIGR and CD79A), and secretory IgA concentration in the gut. The concentration of targeted microbial groups was evaluated with quantitative PCR in the gut digesta collected at d 7 of life. Early SCB supplementation did not impair immunoglobulin absorption and all calves had successful passive transfer of immunity (serum IgG concentration >15 mg/mL at d 1 and d 7 of age). Although the expression of IgA relative gene expression (PIGR and CD79A) was not different, SCB calves had higher secretory IgA concentrations in the ileum (1.98 +/- 0.12 mg/g of dry matter; DM) and colon (1.45 +/- 0.12 mg/g of DM) digesta compared with control animals (1.18 and 0.59 +/- 0.12 mg/g of DM, respectively). In addition, the number of IgA-producing plasma cells were greater in both ileum (2.55 +/- 0.40 cells/mm(2)) and colon (3.03 +/- 0.40 cells/mm(2)) tissues for SCB calves compared with control (respectively 1.00 +/- 0.40 and 0.60 +/- 0.42 cells/mm(2)). Endogenous IgA production in the gut of SCB calves was enhanced, which could make them less prone to pathogen intrusion. In addition, SCB calves had higher Lactobacillus and tended to have higher Faecalibacterium prausnitzii in the jejunum compared with control calves, which suggests that SCB supplementation during early-life gut colonization may have a positive effect in newborn calves. Direct SCB supplementation or the cross-talk between SCB and bacteria may be responsible for stimulating IgA production and may play a key role in shaping early colonization in the gut of newborn calves.
引用
收藏
页码:8615 / 8628
页数:14
相关论文
共 26 条
  • [21] Safety and efficacy of a feed additive consisting of Saccharomyces cerevisiae CNCM I-1079 for calves, all other ruminant species and camelids for rearing and for fattening (Danstart Ferment AG)
    Bampidis, Vasileios
    Azimonti, Giovanna
    Bastos, Maria de Lourdes
    Christensen, Henrik
    Dusemund, Birgit
    Durjava, Mojca Fasmon
    Kouba, Maryline
    Lopez-Alonso, Marta
    Puente, Secundino Lopez
    Marcon, Francesca
    Mayo, Baltasar
    Pechova, Alena
    Petkova, Mariana
    Ramos, Fernando
    Sanz, Yolanda
    Villa, Roberto Edoardo
    Woutersen, Ruud
    Anguita, Montserrat
    Galobart, Jaume
    Ortuno, Jordi
    Pettenati, Elisa
    Brozzi, Rosella
    EFSA JOURNAL, 2022, 20 (10)
  • [22] Saccharomyces Cerevisiae var. Boulardii CNCM I-1079 during late gestation and lactation improves voluntary feed intake, milk production and litter performance of mixed-parity sows in a tropical humid climate
    Domingos, R. L.
    Silva, B. A. N.
    Laguna, F. Bravo de
    Araujo, W. A. G.
    Goncalves, M. F.
    Rebordoes, F. I. G.
    Evangelista, R. P.
    Alkmim, T. C. C. de
    Miranda, H. A. F.
    Cardoso, H. M. C.
    Cardoso, L. A.
    Habit, S. R.
    Motta, S. A. B. da
    ANIMAL FEED SCIENCE AND TECHNOLOGY, 2021, 272
  • [23] Effects of probiotics Pediococcus acidilactici strain MA18/5M and Saccharomyces cerevisiae subsp boulardii strain SB-CNCM I-1079 on fecal and intestinal microbiota of nursing and weanling piglets
    Brousseau, J. -P.
    Talbot, G.
    Beaudoin, F.
    Lauzon, K.
    Roy, D.
    Lessard, M.
    JOURNAL OF ANIMAL SCIENCE, 2015, 93 (11) : 5313 - 5326
  • [24] Saccharomyces Cerevisiae Var Boulardii CNCM I-1079 Reduces Expression of Genes Involved in Inflammatory Response in Porcine Cells Challenged by Enterotoxigenic E. Coli and Influences Bacterial Communities in an In Vitro Model of the Weaning Piglet Colon
    Gresse, Raphaele
    Garrido, Juan J.
    Jimenez-Marin, Angeles
    Denis, Sylvain
    Van de Wiele, Tom
    Forano, Evelyne
    Blanquet-Diot, Stephanie
    Chaucheyras-Durand, Frederique
    ANTIBIOTICS-BASEL, 2021, 10 (09):
  • [25] Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus rhamnosus CNCM I-1720, Lactobacillus helveticus CNCM I-1722, Bifidobacterium longum subsp. longum CNCM I-3470 and Saccharomyces cerevisiae var. boulardii CNCM I-1079 and defence against pathogenic gastro-intestinal microorganisms (ID 3017, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhuser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2012, 10 (08)
  • [26] Scientific Opinion on the substantiation of health claims related to Saccharomyces cerevisiae var. boulardii CNCM I-1079 and defence against pathogenic gastro-intestinal microorganisms (ID 913, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhauser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2012, 10 (06)